Sequence of Currently Approved Systemic Therapies for HCC: From First Line to Second Line and Beyond

Catherine Frenette, MD

Supported by educational grants from Bristol-Myers Squibb, Eisai and Merck.

This recorded webinar is for educational purposes only and is non-accredited.